MesylatesErgoloid MesylatesAminationPalladiumArea Under CurveHalf-LifePharmacokineticsMetabolic Clearance RateBiological AvailabilityAdministration, OralDrug InteractionsInfusions, IntravenousDose-Response Relationship, DrugInjections, IntravenousDrug Administration ScheduleModels, BiologicalTissue DistributionChromatography, High Pressure LiquidNeoplasmsCross-Over StudiesMaximum Tolerated DoseTherapeutic EquivalencyAntineoplastic AgentsProdrugs